Literature DB >> 23422873

Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.

M V Relling1, E E Gardner, W J Sandborn, K Schmiegelow, C-H Pui, S W Yee, C M Stein, M Carrillo, W E Evans, J K Hicks, M Schwab, T E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23422873      PMCID： PMC3604643          DOI： 10.1038/clpt.2013.4

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors:  M V Relling; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

3.  Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.

Authors:  Y González-Lama; F Bermejo; A López-Sanromán; V García-Sánchez; M Esteve; J L Cabriada; A G McNicholl; R Pajares; F Casellas; O Merino; D Carpio; M I Vera; C Muñoz; M Calvo; L M Benito; L Bujanda; F J García-Fernández; E Ricart; D Ginard; M Velasco; J A Carneros; N Manceñido; M Calvo; A Algaba; C Froilan; C Cara; J Maté; L Abreu; J P Gisbert
Journal:  Aliment Pharmacol Ther       Date:  2011-07-03       Impact factor: 8.171

4.  Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.

Authors:  Tiphaine Adam de Beaumais; May Fakhoury; Yves Medard; Said Azougagh; Daolun Zhang; Karima Yakouben; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

Review 5.  Drug methylation in cancer therapy: lessons from the TPMT polymorphism.

Authors:  Eugene Krynetski; William E Evans
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867
  5 in total
  128 in total

1.  Opportunities and limitations: the value of pharmacogenetics in clinical practice.

Authors:  Ann K Daly; Ingolf Cascorbi
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

2.  TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation.

Authors:  Jackson J Liang; Jennifer R Geske; Barry A Boilson; Robert P Frantz; Brooks S Edwards; Sudhir S Kushwaha; Walter K Kremers; Richard M Weinshilboum; Naveen L Pereira
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089

3.  DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.

Authors:  Hee Young Ju; Ji Won Lee; Hee Won Cho; Ju Kyung Hyun; Youngeun Ma; Eun Sang Yi; Keon Hee Yoo; Ki Woong Sung; Rihwa Choi; Hong Hoe Koo; Soo-Youn Lee
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 4.  Pharmacogenomics: personalizing pediatric heart transplantation.

Authors:  Sara L Van Driest; Steven A Webber
Journal:  Circulation       Date:  2015-02-03       Impact factor: 29.690

5.  Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Authors:  Matthew T Oetjens; Joshua C Denny; Marylyn D Ritchie; Niloufar B Gillani; Danielle M Richardson; Nicole A Restrepo; Jill M Pulley; Holli H Dilks; Melissa A Basford; Erica Bowton; Dan R Masys; Russell A Wilke; Dan M Roden; Dana C Crawford
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

Review 6.  Biomarkers of adverse drug reactions.

Authors:  Daniel F Carr; Munir Pirmohamed
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-26

7.  Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.

Authors:  Natalia Sutiman; Sylvia Chen; Khoon Lin Ling; Sai Wei Chuah; Wai Fook Leong; Vinayak Nadiger; Madeline Tjai; Chris San Choon Kong; Brian John Schwender; Webber Chan; Hang Hock Shim; Wee Chian Lim; Chiea Chuen Khor; Yin Bun Cheung; Balram Chowbay
Journal:  Pharmacogenomics       Date:  2017-12-06       Impact factor: 2.533

Review 8.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

Review 9.  CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis.

Authors:  Maxime Meloche; Michael Khazaka; Imad Kassem; Amina Barhdadi; Marie-Pierre Dubé; Simon de Denus
Journal:  Br J Clin Pharmacol       Date:  2020-04-05       Impact factor: 4.335

Review 10.  Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Authors:  Keith T Schmidt; Cindy H Chau; Douglas K Price; William D Figg
Journal:  J Clin Pharmacol       Date:  2016-06-17       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.